Global Tadalafil Oral Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 166

Report ID: 224614

Tadalafil (INN) is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED).

According to this study, over the next five years the Tadalafil Oral market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Tadalafil Oral business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Tadalafil Oral market by product type, application, key manufacturers and key regions and countries.

This study considers the Tadalafil Oral value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
2.5 mg tablets
5 mg tablets
10mg tablets
20 mg tablets
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Eli Lilly
Teva
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan
Accord Healthcare
Cipla
Ajanta Pharma Ltd.
Dr. Reddys Laboratories
Qilu Pharmaceutical
Lupin

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Tadalafil Oral consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Tadalafil Oral market by identifying its various subsegments.
Focuses on the key global Tadalafil Oral manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tadalafil Oral with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Tadalafil Oral submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Tadalafil Oral Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tadalafil Oral Consumption 2013-2023
2.1.2 Tadalafil Oral Consumption CAGR by Region
2.2 Tadalafil Oral Segment by Type
2.2.1 2.5 mg tablets
2.2.2 5 mg tablets
2.2.3 10mg tablets
2.2.4 20 mg tablets
2.3 Tadalafil Oral Consumption by Type
2.3.1 Global Tadalafil Oral Consumption Market Share by Type (2013-2018)
2.3.2 Global Tadalafil Oral Revenue and Market Share by Type (2013-2018)
2.3.3 Global Tadalafil Oral Sale Price by Type (2013-2018)
2.4 Tadalafil Oral Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Tadalafil Oral Consumption by Application
2.5.1 Global Tadalafil Oral Consumption Market Share by Application (2013-2018)
2.5.2 Global Tadalafil Oral Value and Market Share by Application (2013-2018)
2.5.3 Global Tadalafil Oral Sale Price by Application (2013-2018)

3 Global Tadalafil Oral by Players
3.1 Global Tadalafil Oral Sales Market Share by Players
3.1.1 Global Tadalafil Oral Sales by Players (2016-2018)
3.1.2 Global Tadalafil Oral Sales Market Share by Players (2016-2018)
3.2 Global Tadalafil Oral Revenue Market Share by Players
3.2.1 Global Tadalafil Oral Revenue by Players (2016-2018)
3.2.2 Global Tadalafil Oral Revenue Market Share by Players (2016-2018)
3.3 Global Tadalafil Oral Sale Price by Players
3.4 Global Tadalafil Oral Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Tadalafil Oral Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Tadalafil Oral Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Tadalafil Oral by Regions
4.1 Tadalafil Oral by Regions
4.1.1 Global Tadalafil Oral Consumption by Regions
4.1.2 Global Tadalafil Oral Value by Regions
4.2 Americas Tadalafil Oral Consumption Growth
4.3 APAC Tadalafil Oral Consumption Growth
4.4 Europe Tadalafil Oral Consumption Growth
4.5 Middle East & Africa Tadalafil Oral Consumption Growth

5 Americas
5.1 Americas Tadalafil Oral Consumption by Countries
5.1.1 Americas Tadalafil Oral Consumption by Countries (2013-2018)
5.1.2 Americas Tadalafil Oral Value by Countries (2013-2018)
5.2 Americas Tadalafil Oral Consumption by Type
5.3 Americas Tadalafil Oral Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Tadalafil Oral Consumption by Countries
6.1.1 APAC Tadalafil Oral Consumption by Countries (2013-2018)
6.1.2 APAC Tadalafil Oral Value by Countries (2013-2018)
6.2 APAC Tadalafil Oral Consumption by Type
6.3 APAC Tadalafil Oral Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Tadalafil Oral by Countries
7.1.1 Europe Tadalafil Oral Consumption by Countries (2013-2018)
7.1.2 Europe Tadalafil Oral Value by Countries (2013-2018)
7.2 Europe Tadalafil Oral Consumption by Type
7.3 Europe Tadalafil Oral Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Tadalafil Oral by Countries
8.1.1 Middle East & Africa Tadalafil Oral Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Tadalafil Oral Value by Countries (2013-2018)
8.2 Middle East & Africa Tadalafil Oral Consumption by Type
8.3 Middle East & Africa Tadalafil Oral Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Tadalafil Oral Distributors
10.3 Tadalafil Oral Customer

11 Global Tadalafil Oral Market Forecast
11.1 Global Tadalafil Oral Consumption Forecast (2018-2023)
11.2 Global Tadalafil Oral Forecast by Regions
11.2.1 Global Tadalafil Oral Forecast by Regions (2018-2023)
11.2.2 Global Tadalafil Oral Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Tadalafil Oral Forecast by Type
11.8 Global Tadalafil Oral Forecast by Application

12 Key Players Analysis
12.1 Eli Lilly
12.1.1 Company Details
12.1.2 Tadalafil Oral Product Offered
12.1.3 Eli Lilly Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Eli Lilly News
12.2 Teva
12.2.1 Company Details
12.2.2 Tadalafil Oral Product Offered
12.2.3 Teva Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Teva News
12.3 Aurobindo
12.3.1 Company Details
12.3.2 Tadalafil Oral Product Offered
12.3.3 Aurobindo Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Aurobindo News
12.4 Sun Pharma
12.4.1 Company Details
12.4.2 Tadalafil Oral Product Offered
12.4.3 Sun Pharma Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sun Pharma News
12.5 Alembic Pharmaceuticals
12.5.1 Company Details
12.5.2 Tadalafil Oral Product Offered
12.5.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Alembic Pharmaceuticals News
12.6 Mylan
12.6.1 Company Details
12.6.2 Tadalafil Oral Product Offered
12.6.3 Mylan Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Mylan News
12.7 Accord Healthcare
12.7.1 Company Details
12.7.2 Tadalafil Oral Product Offered
12.7.3 Accord Healthcare Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Accord Healthcare News
12.8 Cipla
12.8.1 Company Details
12.8.2 Tadalafil Oral Product Offered
12.8.3 Cipla Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Cipla News
12.9 Ajanta Pharma Ltd.
12.9.1 Company Details
12.9.2 Tadalafil Oral Product Offered
12.9.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Ajanta Pharma Ltd. News
12.10 Dr. Reddys Laboratories
12.10.1 Company Details
12.10.2 Tadalafil Oral Product Offered
12.10.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Dr. Reddys Laboratories News
12.11 Qilu Pharmaceutical
12.12 Lupin

13 Research Findings and Conclusion